triazoles has been researched along with Esophageal Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Azar, MM; Pischel, L; Ringer, M | 1 |
| Azie, N; Ghannoum, M; Schmitt-Hoffmann, AH; Viljoen, J | 1 |
| Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D | 1 |
| Winslow, DL | 1 |
| Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG | 1 |
| Atkinson, G; Denning, DW; Hollis, S; Hood, SV; Percy, M; Williams, K | 1 |
| Aguirrebengoa, K; Ally, R; Carosi, G; Dupont, B; Hodges, M; Kreisel, W; Romero, AJ; Schürmann, D; Troke, P | 1 |
| Hendel, L; Kieffer, M; Stenderup, A; Svejgaard, E; Walsøe, I | 1 |
4 trial(s) available for triazoles and Esophageal Diseases
| Article | Year |
|---|---|
A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Male; Nitriles; Pyridines; Triazoles | 2015 |
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles | 2007 |
Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome; Triazoles | 1999 |
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Consumer Product Safety; Double-Blind Method; Esophageal Diseases; Female; Fluconazole; Humans; Immunocompromised Host; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2001 |
4 other study(ies) available for triazoles and Esophageal Diseases
| Article | Year |
|---|---|
Diagnosis of oesophageal mucormycosis managed with medical therapy alone.
Topics: Amphotericin B; Antifungal Agents; Cytarabine; Esophageal Diseases; Esophagus; Humans; Idarubicin; Immunocompromised Host; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Rhizopus; Triazoles | 2020 |
Posaconazole for azole-refractory candidiasis in patients with HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Administration Schedule; Esophageal Diseases; Humans; Mouth Diseases; Pharyngeal Diseases; Triazoles | 2007 |
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles | 1995 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Triazoles | 1988 |